Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 generics aps - mercaptopurin - tabletter - 50 mg

Europska Unija - danski - EMA (European Medicines Agency)

nova laboratories ireland limited - azathioprine - graft afvisning - immunosuppressiva - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

ratiopharm gmbh - azathioprin - filmovertrukne tabletter - 50 mg

Europska Unija - danski - EMA (European Medicines Agency)

menarini international operations luxembourg s.a. (miol) - febuxostat - gigt - antigout præparater - 80 mg styrke:behandling af kronisk hyperuricaemia i forhold, hvor urat deposition har allerede fundet sted (herunder en historie, eller tilstedeværelsen af, tophus og/eller arthritis urica). adenuric er indiceret hos voksne. 120 mg styrke:adenuric er indiceret til behandling af kronisk hyperuricaemia i forhold, hvor urat deposition har allerede fundet sted (herunder en historie, eller tilstedeværelsen af, tophus og/eller arthritis urica). adenuric er indiceret til forebyggelse og behandling af hyperuricaemia hos voksne patienter, der gennemgår kemoterapi for haematologic maligne sygdomme ved middel til høj risiko for tumor lysis syndrom (tls). adenuric er indiceret hos voksne.

Europska Unija - danski - EMA (European Medicines Agency)

grünenthal gmbh - lesinurad - hyperurikæmi - antigout præparater - zurampic, er i kombination med en xanthin oxidase inhibitor, indiceret hos voksne til adjuverende behandling af hyperurikæmi i gigt patienter (med eller uden tophi), der ikke har nået målet serum urinsyre niveauer med en passende dosis af en xanthin oxidase inhibitor alene.

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

vetoquinol s.a. - praziquantel - tabletter - 50 mg

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

vetoquinol s.a. - febantel, praziquantel, pyrantelembonat - tabletter - 525 + 175 + 504 mg

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

vetoquinol s.a. - praziquantel, pyrantelembonat - filmovertrukne tabletter - 20 + 230 mg

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

vetoquinol s.a. - febantel, pyrantelembonat - oral suspension - 15 mg/ml + 5 mg/ml

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

vetoquinol scandinavia ab - amoxicillintrihydrat, clavulansyre - tabletter - 600+150 mg